|
The Asthma and Allergy Foundation of America (AAFA), the National Basketball Association (NBA) and Teva Specialty Pharmaceuticals-USA (TSP) have come together to help you better understand and care for your asthma, to improve your quality of life.
The asthma education campaign -- "Are You Ready to Go Pro?" -- offers free information and resources to teach you about asthma prevention, management and treatment.
Manage Your Asthma Like A Pro
Visit with your doctor to update your asthma management plan, and click the links and tabs on this page for more tips, infomation and tools to help you manage your asthma like a pro!
To speak with a member of AAFA's External Affairs staff call toll-free 1-800-7-ASTHMA or write to info@aafa.org.
To learn more about the NBA visit www.NBA.com.
This program is made possible by a grant from Teva Specialty Pharmaceuticals-USA.
ProAir HFA Indication
ProAir HFA is indicated in adults and children 12 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm.
ProAir HFA Fair Balance Statement
ProAir HFA is indicated in adults and children 12 years of age and older for the treatment or prevention of bronchospasm with reversible obstructive airway disease and for the prevention of exercise-induced bronchospasm. Inhaled albuterol sulfate can produce paradoxical bronchospasm that may be life threatening. It should be recognized that paradoxical bronchospasm, when associated with inhaled formulations, frequently occurs with the first use of a new canister. ProAir HFA, as with all sympathomimetic amines, should be used with caution in patients with cardiovascular disorders (especially coronary insufficiency, cardiac arrhythmias, and hypertension), convulsive disorders, hyperthyroidism, and diabetes. Do not exceed the recommended dose. Fatalities have been reported in association with excessive use of inhaled sympathomimetic drugs in patients with asthma. Potential drug interactions can occur with beta blockers, diuretics, digoxin, or monoamine oxidase inhibitor and tricyclic antidepressants. Adverse events, which occurred at an incidence rate of at least 3% with ProAir HFA, include headache, tachycardia, pain, dizziness, pharyngitis and rhinits.
See complete Prescribing Information
See the ProAir Brief Summary
|
